HALOZYME THERAPEUTICS, INC.: 10-K filed 2014-02-28

Name: HALOZYME THERAPEUTICS, INC.: 10-K filed 2014-02-28
Creator: HALOZYME THERAPEUTICS, INC.

What HALOZYME THERAPEUTICS, INC. reported in its annual report filed 2014-02-28 (fiscal FY 2013): 36 published measures, 116 facts as tagged in accession 0001159036-14-000033.

This filing

Form: 10-K (annual report)
Filed: 2014-02-28
Fiscal period: fiscal FY 2013
Accession: 0001159036-14-000033 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HALOZYME THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-12-31	101,792,592	USD
At 2012-12-31	134,728,397	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2013-12-31	-19,990,676	USD
At 2012-12-31	48,853,719	USD
At 2011-12-31	10,900,116	USD
At 2010-12-31	20,351,456	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-12-31	27,356,947	USD
At 2012-12-31	99,501,264	USD
At 2011-12-31	52,375,527	USD
At 2010-12-31	82,755,848	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	-21,986,303	USD	92
2013-01-01 to 2013-12-31	-83,478,551	USD	365
2013-07-01 to 2013-09-30	-19,292,368	USD	92
2013-04-01 to 2013-06-30	-22,911,511	USD	91
2013-01-01 to 2013-03-31	-19,288,369	USD	90
2012-10-01 to 2012-12-31	-4,405,856	USD	92
2012-01-01 to 2012-12-31	-53,552,002	USD	366
2012-07-01 to 2012-09-30	-20,005,846	USD	92
2012-04-01 to 2012-06-30	-14,021,119	USD	91
2012-01-01 to 2012-03-31	-15,119,181	USD	91
2011-01-01 to 2011-12-31	-19,769,851	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-49,339,479	USD	365
2012-01-01 to 2012-12-31	-64,279,296	USD	366
2011-01-01 to 2011-12-31	-34,300,425	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	2,297,518	USD	365
2012-01-01 to 2012-12-31	1,412,585	USD	366
2011-01-01 to 2011-12-31	828,508	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	12,498,933	USD	92
2013-01-01 to 2013-12-31	54,799,447	USD	365
2013-07-01 to 2013-09-30	16,013,164	USD	92
2013-04-01 to 2013-06-30	14,453,810	USD	91
2013-01-01 to 2013-03-31	11,833,540	USD	90
2012-10-01 to 2012-12-31	21,793,549	USD	92
2012-01-01 to 2012-12-31	42,325,226	USD	366
2012-07-01 to 2012-09-30	5,334,323	USD	92
2012-04-01 to 2012-06-30	7,757,175	USD	91
2012-01-01 to 2012-03-31	7,440,179	USD	91
2011-01-01 to 2011-12-31	56,086,436	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	25,064,296	USD	365
2012-01-01 to 2012-12-31	112,817,618	USD	366
2011-01-01 to 2011-12-31	4,748,612	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-47,869,134	USD	365
2012-01-01 to 2012-12-31	-1,412,585	USD	366
2011-01-01 to 2011-12-31	-828,508	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-12-31	-382,052,199	USD
At 2012-12-31	-298,573,648	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-12-31	3,421,506	USD
At 2012-12-31	3,700,462	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	9,538,056	USD	365
2012-01-01 to 2012-12-31	8,348,587	USD	366
2011-01-01 to 2011-12-31	5,569,899	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-80,433,637	USD	365
2012-01-01 to 2012-12-31	-53,625,446	USD	366
2011-01-01 to 2011-12-31	-19,838,941	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-12-31	95,195,394	USD
At 2012-12-31	130,627,935	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	3,274,143	USD	365
2012-01-01 to 2012-12-31	0	USD	366
2011-01-01 to 2011-12-31	0	USD	365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-12-31	25,453,032	USD
At 2012-12-31	18,946,153	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-12-31	3,134,757	USD
At 2012-12-31	2,271,689	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2013-12-31	9,097,084	USD
At 2012-12-31	15,703,087	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2013-12-31	6,169,982	USD
At 2012-12-31	2,670,696	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	6,266,250	USD	92
2013-07-01 to 2013-09-30	9,342,187	USD	92
2013-04-01 to 2013-06-30	1,815,903	USD	91
2013-01-01 to 2013-03-31	769,623	USD	90
2012-10-01 to 2012-12-31	805,851	USD	92
2012-07-01 to 2012-09-30	488,719	USD	92
2012-04-01 to 2012-06-30	381,822	USD	91
2012-01-01 to 2012-03-31	116,650	USD	91

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	32,347,748	USD	365
2012-01-01 to 2012-12-31	24,812,199	USD	366
2011-01-01 to 2011-12-31	18,104,073	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	96,639,575	USD	365
2012-01-01 to 2012-12-31	70,044,073	USD	366
2011-01-01 to 2011-12-31	57,563,470	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-12-31	114,533,466	shares
At 2012-12-31	112,709,174	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2013-12-31	17,054	USD
At 2012-12-31	0	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2013-12-31	49,771,737	USD
At 2012-12-31	29,661,680	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2013-12-31	11,070,734	USD
At 2012-12-31	10,381,089	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2013-12-31	7,649,228	USD
At 2012-12-31	6,680,627	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2013-12-31	18,268	USD
At 2012-12-31	0	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-12-31	14,920,446	USD
At 2012-12-31	7,783,447	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2013-12-31	8,425,684	USD
At 2012-12-31	12,752,888	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2013-12-31	143,000	USD
At 2012-12-31	0	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-83,461,497	USD	365
2012-01-01 to 2012-12-31	-53,552,002	USD	366
2011-01-01 to 2011-12-31	-19,769,851	USD	365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	1,226,927	USD	365
2012-01-01 to 2012-12-31	1,079,424	USD	366
2011-01-01 to 2011-12-31	1,095,823	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2014-02-09 to 2014-02-10	107,800,000	USD	2
2013-01-01 to 2013-12-31	0	USD	365
2012-01-01 to 2012-12-31	81,476,845	USD	366
2012-02-01 to 2012-02-29	81,500,000	USD	29
2011-01-01 to 2011-12-31	0	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-6,606,003	USD	365
2012-01-01 to 2012-12-31	13,440,622	USD	366
2011-01-01 to 2011-12-31	-65,803	USD	365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	3,499,286	USD	365
2012-01-01 to 2012-12-31	2,103,433	USD	366
2011-01-01 to 2011-12-31	373,841	USD	365

Inspect the source

Entity: HALOZYME THERAPEUTICS, INC. / CIK 0001159036
Captured: 2026-09-19T11:16:42.578Z
SEC response SHA-256: 09ca2466c06425bbd1ba706e3a09155b9a42131078735be72a3a1bd471a407ac

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001159036.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))